Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CAI Caris Life Sciences, Inc.

Market Closed 01-09 16:00:00 EST

28.51

+0.26

+0.92%

盘后28.65

+0.14+0.49%

19:26 EST

High28.68	Low27.58	Vol1.95M
Open28.43	D1 Closing28.25	Amplitude3.89%
Mkt Cap8.04B	Tradable Cap2.62B	Total Shares282.15M
T/O55.13M	T/O Rate2.12%	Tradable Shares91.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":28.51,"timestamp":1767992400000,"preClose":28.25,"halted":0,"volume":1946092,"hourTrading":{"tag":"盘后","latestPrice":28.65,"preClose":28.51,"latestTime":"19:26 EST","volume":7665,"amount":218565.4,"timestamp":1768004772051},"delay":0,"floatShares":91917486,"shares":282146923,"eps":-2.417,"marketStatus":"Market Closed","change":0.26,"latestTime":"01-09 16:00:00 EST","open":28.43,"high":28.68,"low":27.58,"amount":55128127.415752,"amplitude":0.038938,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.417,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":28.25,"preHourTrading":{"tag":"盘前","latestPrice":28.44,"preClose":28.25,"latestTime":"09:27 EST","volume":5174,"amount":142470.855254,"timestamp":1767968836535},"postHourTrading":{"tag":"盘后","latestPrice":28.65,"preClose":28.51,"latestTime":"19:26 EST","volume":7665,"amount":218565.4,"timestamp":1768004772051},"volumeRatio":0.736444700994122,"impliedVol":0.9033,"impliedVolPercentile":0.9143},"requestUrl":"/m/hq/s/CAI","defaultTab":"news","newsList":[{"id":"2601688439","title":"Caris Life Sciences to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601688439","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601688439?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:31","pubTimestamp":1767619863,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. will present and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California. Caris is scheduled to present on Monday, January 12 at 1:30 PM PT, with live and replay webcasts available on the Investor Relations section of the company’s website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL8vnLs0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4104","BK4139"],"gpt_icon":0},{"id":"2600051108","title":"CAI Corp's CFO Steps Down; Shares Surge 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600051108","media":"MT Newswires Live","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600051108?lang=en_us&edition=fundamental","pubTime":"2026-01-02 15:47","pubTimestamp":1767340030,"startTime":"0","endTime":"0","summary":"CAI Corp's (HKG:0080) chief financial officer, Tai Man Hin Tony, resigned, effective Wednesday, to pursue other career opportunities, according to a same-day Hong Kong bourse filing.Shares of the securities investor were up over 7% in Friday afternoon trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAI"],"gpt_icon":0},{"id":"1183965920","title":"CAI Holdings (00080): Dai Wenxuan Steps Down as Company CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=1183965920","media":"Stock News","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183965920?lang=en_us&edition=fundamental","pubTime":"2025-12-31 12:36","pubTimestamp":1767155774,"startTime":"0","endTime":"0","summary":"Dai Wenxuan has resigned from his position as the Chief Financial Officer of the company to pursue other career opportunities, with his final employment date set for December 31, 2025.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00080","BK4139","BK4104","CAI","BK1511"],"gpt_icon":0},{"id":"2593448712","title":"Caris Life Sciences Is Maintained at Hold by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2593448712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593448712?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:54","pubTimestamp":1766408040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 22, 2025 07:54 ET (12:54 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2592827167","title":"Providence Swedish Cancer Institute Joins Caris Precision Oncology Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2592827167","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592827167?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:30","pubTimestamp":1766151024,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc., a leader in precision medicine and next-generation AI-driven oncology, has announced that the Providence Swedish Cancer Institute and its translational research extension, the Paul G. Allen Research Center, have joined the Caris Precision Oncology Alliance . This collaboration aims to accelerate access to cutting-edge cancer therapies by leveraging shared resources, comprehensive molecular profiling, and one of the industry’s largest multimodal databases. Through this partnership, the institutions will work together to advance precision oncology, participate in biomarker-driven clinical trials, and improve patient outcomes by prioritizing innovative, data-driven treatment options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLb0Zx48:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"1109838216","title":"CNEWECON FUND (00080) Plans to Acquire 9.09% Stake in Forestheaven and 3.15% Stake in EXIO from Controlling Shareholder","url":"https://stock-news.laohu8.com/highlight/detail?id=1109838216","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109838216?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:20","pubTimestamp":1765974020,"startTime":"0","endTime":"0","summary":"CNEWECON FUND (00080) announced that on December 17, 2025, the company (as the buyer) entered into a share transfer agreement with Longling Capital (as the seller) to acquire approximately 9.09% of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1511","00080","CAI","BK4104","BK4139"],"gpt_icon":0},{"id":"2592318159","title":"Caris Life Sciences Shares Add 2% After Co Signs Genentech Deal for Rare Cancer Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2592318159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592318159?lang=en_us&edition=fundamental","pubTime":"2025-12-17 01:54","pubTimestamp":1765907657,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nL4N3XM13Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2591933563","title":"BRIEF-Caris Life Sciences Announces Collaboration With Genentech","url":"https://stock-news.laohu8.com/highlight/detail?id=2591933563","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591933563?lang=en_us&edition=fundamental","pubTime":"2025-12-16 23:00","pubTimestamp":1765897209,"startTime":"0","endTime":"0","summary":"BRIEF-Caris Life Sciences Announces Collaboration With Genentech Dec 16 (Reuters) - Caris Life Sciences Inc CAI.O:CARIS LIFE SCIENCES ANNOUNCES COLLABORATION WITH GENENTECH TO DISCOVER NOVEL THERAPEUT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA9SPVCV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2591698200","title":"Caris Life Sciences Partners with Genentech to Identify Novel Cancer Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2591698200","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591698200?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:31","pubTimestamp":1765891865,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. has announced a multi-year collaboration and license agreement with Genentech, a member of the Roche Group. The partnership aims to identify and validate novel therapeutic targets in solid tumor cancers with high unmet clinical need. Under the agreement, Caris will receive $25 million in upfront and near-term payments and may earn up to $1.1 billion in potential milestone payments, as well as tiered royalties on net sales of resulting therapies. The collaboration combines Caris' advanced multimodal data and discovery capabilities with Genentech's expertise in therapeutic development to accelerate the creation of innovative cancer treatments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL77rYX2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2591827779","title":"Caris Life Sciences Announces Collaboration With Genentech to Discover Novel Therapeutic Targets in Cancers With High Unmet Clinical Need","url":"https://stock-news.laohu8.com/highlight/detail?id=2591827779","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591827779?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:30","pubTimestamp":1765891803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA9SPVCV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAI","BK4104","BK4139"],"gpt_icon":0},{"id":"2591820539","title":"Caris Life Sciences Inc - Eligible for $25 Mln Upfront and $1.1 Bln in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2591820539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591820539?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:30","pubTimestamp":1765891803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA9SPVCV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"1118944442","title":"CNEWECON FUND (00080) Reports NAV per Share of HK$0.14 as of End-November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1118944442","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118944442?lang=en_us&edition=fundamental","pubTime":"2025-12-15 16:46","pubTimestamp":1765788382,"startTime":"0","endTime":"0","summary":"CNEWECON FUND (00080) announced that as of November 30, 2025, the unaudited net asset value (NAV) per share of the company and its subsidiaries stood at HK$0.14.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","00080","BK4104","BK4139","BK1511"],"gpt_icon":0},{"id":"2591768059","title":"Caris Life Sciences CFO Luke Thomas Power Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2591768059","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591768059?lang=en_us&edition=fundamental","pubTime":"2025-12-13 08:39","pubTimestamp":1765586391,"startTime":"0","endTime":"0","summary":"Luke Thomas Power, Senior Vice President, Chief Financial Officer, and Chief Accounting Officer of Caris Life Sciences Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251213:nNDL2tCQt7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Caris Life Sciences CFO Luke Thomas Power Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"1174957882","title":"CAI LIAN HE Approved as President of RuiTai Life Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=1174957882","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174957882?lang=en_us&edition=fundamental","pubTime":"2025-12-05 18:11","pubTimestamp":1764929465,"startTime":"0","endTime":"0","summary":"On December 5, the Beijing Financial Regulatory Bureau announced its approval, granting CAI LIAN HE the qualification to serve as President of RuiTai Life Insurance Co., Ltd.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HE","CAI","BK4139","BK4081","BK4104"],"gpt_icon":0},{"id":"2588882429","title":"Caris Life Sciences Unveils 19 New Breast Cancer Studies at 2025 SABCS","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588882429?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:30","pubTimestamp":1764855026,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. announced that it will present 19 studies at the upcoming 2025 San Antonio Breast Cancer Symposium , scheduled for December 9-12, 2025. The studies, conducted in collaboration with leading cancer centers and members of the Caris Precision Oncology Alliance, cover a range of breast cancer types and focus on advancements in multimodal AI for recurrence prediction and risk stratification in early and late breast cancer. Highlights include an oral presentation on AI models integrating image, clinical, and molecular data for recurrence prediction, and a rapid oral presentation on a deep learning model for late distant recurrence risk in HR+ early breast cancer. The results of these studies will be presented at SABCS 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDLF3Rn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2588635850","title":"IP Oh No? Recent Stock Market Debuts Have Fizzled. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2588635850","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588635850?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:52","pubTimestamp":1764701520,"startTime":"0","endTime":"0","summary":"So much for the comeback for initial public offerings.Sure, companies like Circle Internet Group and Figma enjoyed stellar debuts this summer, surging from their IPO prices. But since then, several high-profile offerings -- such as StubHub, Gemini Space Station, Klarna, Fermi, and Navan -- have flopped. All five are trading well below both their IPO prices and their first-day closing prices.In fact, only two of the 20 largest IPOs of the past six months were trading above their debut day closing prices as of December 1, according to FactSet and Dow Jones Market Data. Shares of education publishing company McGraw Hill are up nearly 2% from where they ended their first trading day in late July, while blockchain lending company Figure Technology Solutions has gained about 13% since its IPO on September 10.The more favorable environment for IPOs -- combined with the Trump administration and Congress' embrace of stablecoins and other digital assets -- should lead to more crypto IPOs as well","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APT.USD.CC","BK4192","BK4023","IP","BK4136","CAI","BK4139","APT.USD.HKCC","LU1487256676.USD","TON.USD.HKCC","GEMI","BK4588","LU1169589451.USD","LU2463526074.USD","LU1169590202.USD","CBC","BK4104","IE00B3T34201.USD","STUB","BK4211","LU1481600234.SGD","BK4585","BK4112","LU1481599808.USD","TON.USD.CC"],"gpt_icon":1},{"id":"2588552680","title":"Caris Life Sciences Welcomes UAMS Winthrop P. Rockefeller Cancer Institute to Precision Oncology Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2588552680","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588552680?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:30","pubTimestamp":1764682232,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc., a leader in precision medicine, has announced that the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences  has joined the Caris Precision Oncology Alliance. This global network consists of 98 cancer centers, including 45 NCI-designated institutions, collaborating to advance precision oncology and biomarker-driven research. Through this partnership, UAMS will leverage Caris' comprehensive molecular profiling and access one of the industry's largest multi-modal databases to enhance personalized cancer care and accelerate research discoveries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLVNLCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2588058295","title":"Caris Life Sciences Initiated at Hold by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2588058295","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588058295?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:41","pubTimestamp":1764679260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 07:41 ET (12:41 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2588030713","title":"Canaccord Genuity Initiates Caris Life Sciences at Hold With $28 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2588030713","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588030713?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:15","pubTimestamp":1764677719,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc. (CAI) has an average rating of buy and mean price target of $39.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAI"],"gpt_icon":0},{"id":"2588243907","title":"BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2588243907","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588243907?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:41","pubTimestamp":1764589268,"startTime":"0","endTime":"0","summary":"BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests Dec 1 (Reuters) - Wall Street analysts, who acted as lead underwriters for BillionToOne's BLLN.O Nasdaq debut last m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL4N3X70J1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BLLN","BK4139","BK4196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carislifesciences.com","stockEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":0.052},{"period":"3month","weight":-0.0646},{"period":"6month","weight":0.0754},{"period":"1year","weight":0.3576},{"period":"ytd","weight":0.0567}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":0.003709},{"month":2,"riseRate":0.714286,"avgChangeRate":0.097096},{"month":3,"riseRate":0.785714,"avgChangeRate":0.045627},{"month":4,"riseRate":0.642857,"avgChangeRate":0.069907},{"month":5,"riseRate":0.571429,"avgChangeRate":0.009049},{"month":6,"riseRate":0.4,"avgChangeRate":0.003897},{"month":7,"riseRate":0.533333,"avgChangeRate":0.001503},{"month":8,"riseRate":0.466667,"avgChangeRate":0.000804},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.003567},{"month":10,"riseRate":0.666667,"avgChangeRate":0.042552},{"month":11,"riseRate":0.533333,"avgChangeRate":0.007248},{"month":12,"riseRate":0.4,"avgChangeRate":-0.027079}],"exchange":"NASDAQ","name":"Caris Life Sciences, Inc.","nameEN":"Caris Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Caris Life Sciences, Inc.,CAI,Caris Life Sciences, Inc.股票,Caris Life Sciences, Inc.股票老虎,Caris Life Sciences, Inc.股票老虎国际,Caris Life Sciences, Inc.行情,Caris Life Sciences, Inc.股票行情,Caris Life Sciences, Inc.股价,Caris Life Sciences, Inc.股市,Caris Life Sciences, Inc.股票价格,Caris Life Sciences, Inc.股票交易,Caris Life Sciences, Inc.股票购买,Caris Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}